86. Pulmonary arterial hypertension Clinical trials / Disease details
Clinical trials : 1,181 / Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04451850 (ClinicalTrials.gov) | June 1, 2021 | 25/6/2020 | HRV as a Marker of Treatment Response in PAH Arterial Hypertension | Heart Rate Variability (HRV) as a Marker of Treatment Response in Pulmonary Arterial Hypertension (PAH) | Pulmonary Arterial Hypertension | Other: Noninvasive actigraphy monitor | University of Cincinnati | NULL | Recruiting | 18 Years | 70 Years | All | 35 | United States |